Roche Pill Wins U.S. Clearance After Breast Cancer Trial
Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources
Brief
The Food and Drug Administration on Nov. 16 cleared a Roche pill used with everolimus.
Keep reading with NewsPlain Premium
Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.
5 confirmed facts, 2 open questions and 3 sources behind this story.